Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

TOLNAFTATE POWDER, U

Active
SPE2DP-26-T-4391Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100371 BOX 1, FPO, AE, 09570, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
TOLNAFTATE POWDER,U
TOLNAFTATE POWDER,USP 1%, 45 GM
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
U/I "BT" (45 MG)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
1 BT = 45 GM RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4391
SECTION B
GERI-CARE PHARMACEUTICALS CORP. 06WD3 P/N NDC57896-0199-45
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017680537 0001 BT 1.000
NSN/MATERIAL:6505014807897
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N21525
USNS LEROY GRUMMAN T AO 195
UNIT 100371 BOX 1
FPO AE 09570
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N21525
USNS LEROY GRUMMAN T AO 195
DLA VENDORS: USE VSM FOR
US
SPE2DP-26-T-4391
SECTION B
PR: 7017680537 PRLI: 0001 CONT’D
M/F: (TCN) N215256210S515
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YCAB B SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A4A DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:08/03/2026

DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7017693192 0001 BT 6.000
NSN/MATERIAL:6505014807897
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT PKGING DATA MIL-STD-2073-1E SPECIAL NSN/Part Number: 6505-01-480-7897 Quantity: 1 BT Purchase Request: 7017693221QTY: 2 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMI
Solicitation # SPE2DP-26-T-4394
ERYTHROMYCIN OPHTHALMIC OINTMENT USP is a sterile, topical ointment containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, intended for ophthalmic use only. Each unit is packaged as a single-dose tube containing 3.5 grams of ointment, with 24 tubes per package, defined as the unit of issue. The product must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, as its total shelf life is 36 months and is non-extendable. Storage requirements mandate controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must comply with DLA’s Master List of Technical and Quality Requirements. The ointment is regulated by the FDA and must be marked and shipped in accordance with commercial packaging standards, specifically ASTM D3951 if not classified as hazardous under FED-STD-313; however, DLA requirements take precedence over all other standards. Each shipment must be delivered FOB destination within five days, using the fastest traceable means, excluding parcel post, to the specified delivery point at Fort Lewis, WA. The product is identified by NSN 6505-01-189-7090, with a single purchase order quantity of one package, and the manufacturer is PADAGIS US LLC under NDC 00574-4024-39.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DOXYCYCLINE HYCLATE
Solicitation # SPE2DP-26-T-4150
Doxycycline Hyclate Tablets, USP equivalent to 100 mg of doxycycline, are supplied in film-coated form as unit packs of 100 tablets per bottle, with the unit of issue defined as a bottle (BT). The contract mandates strict adherence to Medical Marking Standard No. 1A dated February 4, 2013, superseding all references to MIL-STD-129, and requires each unit to be sealed in a container that protects against damage and breakage, while exterior shipping containers must ensure safe, cost-effective delivery by common carriers to the designated destination. All packaging and labeling must conform to DLA’s Technical and Quality Requirements, with hazardous material handling governed by FED-STD-313 and ASTM D3951 only if the item is not classified as hazardous, and DLA’s standards take precedence over commercial standards. The product has a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 20 to 25°C (68 to 77°F), protected from light and moisture. The item is regulated by the FDA, and buyers must submit a referral through EBS to confirm bidder and manufacturer details, including NDC62135-0626-01. The total quantity ordered is eight bottles (8 BT), with delivery required within 20 days FOB destination to Fort Bragg, North Carolina, using traceable shipping methods and prohibiting parcel post. The contract prohibits any variance in quantity, and inspection and acceptance occur at the destination. The shipment must be palletized per RP001 requirements and marked with the specified government identifiers, including the NSN 6505016003042 and project code TP 3, with the supplier identified as CHARTWELL RX LLC.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 4 days
View Details
NAICS: 325412
New
Federal
6505--Ticagrelor Tablets
Solicitation # 36E79726R0028
The Department of Veterans Affairs through its National Acquisition Center is preparing to issue an unrestricted solicitation for Ticagrelor Tablets under solicitation number 36E79726R0028, targeting supply to VA facilities including Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is divided into two mutually exclusive groups: Group I includes both 60-count bottles and bulk packaging options of 500 or 1,000 tablets per bottle for both 60mg and 90mg strengths, while Group II includes only 60-count bottles for the same strengths. Offerors must submit complete proposals for one group only, and award will go to the lowest-priced technically acceptable bid based on total evaluated price. The contract has a base term of one year with four optional one-year extensions, and product distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. All offered products must bear the offeror’s unique NDC number and be labeled exclusively with that label, with no over-labelling permitted. VA labels must be capable of adhering securely on top of the contractor’s label. Packaging requirements are strict: unit-of-use bottles must have safety caps with deshellable or convertible features, meet minimum size specifications including 120cc capacity and 5.75-inch circumference, fit a label measuring 5.25 x 2 inches with an additional 0.5 inch for barcodes and expiration details, and feature a cylindrical body. Total annual estimated demand is approximately 21,137 bottles of 60mg 60-count, 141,992 bottles of 90mg 60-count for Group I combined with either 500 or 1,000 tablet bulk options, and for Group II, approximately 52,237 and 205,992 bottles of 60mg and 90mg 60-count respectively. The solicitation will be released electronically on or about August 18, 2026, with a proposed closing date of September 1, 2026, under NAICS code 325412. All information is accessible only through SAM.gov, and inquiries must be directed via email to Kenneth Lay. No paper copies will be provided.
Nac Pharmaceuticals (36E797)

POSTED

about 20 hours ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Tablet Supply – Sumatriptan Succinate 25mgThe contract entails the manufacture and supply of 54,000 units of Sumatriptan Succinate 25mg film-coated tablets intended for the acute treatment of migraines, with strict adherence to current Good Manufacturing Practices (cGMP) requirements to ensure product quality, safety, and consistency. The manufacturing process and final product must comply with controlled storage conditions to maintain stability and efficacy throughout the supply chain, reflecting the sensitive nature of pharmaceutical therapeutics. The procurement is structured as a subcontract under the NAICS code 325412, which designates pharmaceutical preparation manufacturing, and is managed by the Department of Defense through its Medical Supply Chain Pharm FSA agency, with performance required at Fort Bliss, Texas, 79918-2527. The solicitation was posted on July 29, 2026, with a response deadline of August 4, 2026, indicating a tight turn-around for qualified suppliers to submit proposals. The contract is not subject to any set-aside provisions and is publicly accessible via the DIBBS platform, suggesting a competitive bidding process open to eligible contractors capable of meeting federal pharmaceutical standards. Compliance with all regulatory, packaging, labeling, and documentation requirements for defense-related medical supplies will be mandatory, and delivery timelines will likely be tied to operational readiness needs of the military healthcare system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 541611
New
DIBBS
Small Business Subcontracting & Compliance SupportThe contract seeks a vendor to assist the prime contractor in achieving small business subcontracting objectives by identifying, coordinating with, and ensuring compliance for Women-Owned Small Businesses, Service-Disabled Veteran-Owned Small Businesses, and HUBZone certified firms. The support includes proactive outreach to eligible vendors, managing subcontractor relationships, and providing accurate and timely compliance reporting to meet federal small business participation targets. This effort is tied to a Department of Defense initiative under the Medical Supply Chain Pharm FSA, with performance centered at Fort Bliss, Texas, 79918-2527, and aligns with NAICS code 541611 for management consulting services. The opportunity is open for responses until August 4, 2026, with the solicitation posted on July 29, 2026. While no specific set-aside designation is indicated, the work is explicitly structured to enable prime contractors to fulfill their small business subcontracting obligations, particularly through engagement with certified disadvantaged and underrepresented business entities. The contracting vehicle falls under the subcontract category, and all activities must adhere to federal small business programs and reporting requirements applicable to Department of Defense contracts. Interested parties can access further details through the provided DIBBS portal link.
Administrative Management and General Management Consulting Services

POSTED

1 day ago

DEADLINE

in 4 days
View Details